About the Institution
Burzynski Research Institute, Inc. (BRI) is headquartered in Houston, TX and has a research facility in Stafford, TX. BRI was incorporated in 1984 in order to engage in the development of growth-inhibiting peptides, amino acid derivatives and organic acids, which are known under the trade name “Antineoplastons”. Antineoplastons are being investigated in FDA reviewed and Institutional Review Board (IRB) approved clinical trials.
|
